GSK503 25mg 25mg | Purity Not Available
Adooq Bioscience
GSK-503 is a potent EZH2 inhibitor with potential anticancer activity.
More Information Supplier PageSearch Results
GSK503 10mg 10mg | Purity Not Available
Adooq Bioscience
GSK-503 is a potent EZH2 inhibitor with potential anticancer activity.
More Information Supplier PageSU5614 50mg 50mg | Purity Not Available
Adooq Bioscience
SU5614 is a potent and selective FLT3 inhibitor. SU5614 reverts the antiapoptotic and pro-proliferative activity of FLT3 ligand (FL) in FL-dependent cells.
More Information Supplier PageSU5614 25mg 25mg | Purity Not Available
Adooq Bioscience
SU5614 is a potent and selective FLT3 inhibitor. SU5614 reverts the antiapoptotic and pro-proliferative activity of FLT3 ligand (FL) in FL-dependent cells.
More Information Supplier PageSU5614 10mg 10mg | Purity Not Available
Adooq Bioscience
SU5614 is a potent and selective FLT3 inhibitor. SU5614 reverts the antiapoptotic and pro-proliferative activity of FLT3 ligand (FL) in FL-dependent cells.
More Information Supplier PageGSK2879552 5mg 5mg | Purity Not Available
Adooq Bioscience
GSK2879552 is an orally available, irreversible, inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity.
More Information Supplier PageGSK2879552 25mg 25mg | Purity Not Available
Adooq Bioscience
GSK2879552 is an orally available, irreversible, inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity.
More Information Supplier PageGSK2879552 10mg 10mg | Purity Not Available
Adooq Bioscience
GSK2879552 is an orally available, irreversible, inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity.
More Information Supplier Page